当前位置: X-MOL首页全球导师 国内导师 › 胡伟汉

个人简介

1976年毕业于中山医科大学医疗系。现任中山大学附属肿瘤医院放疗科教授、主任医师、硕士生导师。学习及工作经历:  1976年:毕业于中山医学院医疗系  1976至今:中山大学附属肿瘤医院放疗科工作,历任住院医师、主治医生/讲师、副主任医师/副教授、教授/主任医师

研究领域

肿瘤放射治疗(同期放化疗、靶向治疗)的临床工作。特别擅长头颈肿瘤(鼻咽癌、鼻腔副鼻窦癌、口腔、口咽癌、喉癌及下咽癌等)的放射治疗及研究。

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

64. Wei W, Huang Z, Li S, Chen H, Zhang G, Li S, Hu W, Xu T: Pretreatment Epstein-Barr virus DNA load and cumulative cisplatin dose intensity affect long-term outcome of nasopharyngeal carcinoma treated with concurrent chemotherapy: experience of an institute in an endemic area. Oncology research and treatment 2014, 37(3):88-95. (通讯作者) 65. Tao Xu, Weihong Wei, Zeli Huang, Weihan Hu. Case Report: Coexistence of Non-Keratinizing Squamous Cell Carcinoma and Follicular Lymphoma in Nasopharynx. Cancer Research Updates, 2014, 3, 93-96.(通讯作者) 66. 王洪智,孙瑞,胡伟汉.早期喉癌患者人乳头状瘤病毒感染与HRAS、PIK3A突变分析.肿瘤临床与研究. 2014; 26(6):361-372.(通讯作者) 67. Xu T, Huang Z, Su B, Wang S, Wang D, Wang C, Wei W, Jiang J, Zhang G, Yang H, Hu, W.: Prognostic significance of circulating CD19+ B lymphocytes in EBV-associated nasopharyngeal carcinoma. Medical oncology (Northwood, London, England) 2014, 31(10):198.(通讯作者) 68. Tao Xu, Zhiwei Liao, Jun Tang, Li Guo, Huizhi Qiu,Yuanhong Gao, Weihan Hu. Myoepithelial carcinoma of the head and neck: A report of 23 cases and literature review. Cancer Treatment Communications. 2014, 2(2–3): 24–29.(通讯作者) 69. Wei W, Huang Z, Li S, Chen H, Zhang G, Li S, Hu W, Xu T: Pretreatment Epstein-Barr virus DNA load and cumulative cisplatin dose intensity affect long-term outcome of nasopharyngeal carcinoma treated with concurrent chemotherapy: experience of an institute in an endemic area. Oncology research and treatment 2014, 37(3):88-95.(通讯作者) 70.Xu T, Huang Z, Deng Y, Wang S, Su B, Wei W, Wang D, Jiang J, Li A, Zhang G, Yang H, Claret FX, Hu W: Clinical implications of hepatitis B viral infection in Epstein-Barr virus-associated nasopharyngeal carcinoma. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2015, 64:64-71. (通讯作者) 71. Wang H, Zhang Z, Sun R, Lin H, Gong L, Fang M, Hu WH: HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma. Journal of voice : official journal of the Voice Foundation 2015, 29(3):356-362.(通讯作者) 72. Li P, Hu W, Zhu Y, Liu J. Treatment and predictive factors in patients with recurrent laryngeal carcinoma: A retrospective study. Oncology letters 2015; 10(5): 3145-52.(共同第一作者) 73. Li PJ, Jin T, Luo DH, Shen T, Mai DM, Hu WH, Mo HY: Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma. PloS one 2015, 10(10):e0141332. (共同通讯作者) 74.Xu Y, Hu W, Liu Y, Xu P, Li Z, Wu R, Shi X, Tang Y: P2Y6 Receptor-Mediated Microglial Phagocytosis in Radiation-Induced Brain Injury. Molecular neurobiology 2016, 53(6):3552-3564.(共同第一作者) 75. Jin T, Li PJ, Chen XZ, Hu WH. ABO blood group is a predictor of survival in patients with laryngeal cancer. Chinese journal of cancer 2016; 35(1): 90.(共同通讯作者) 76. Liu RB, Guo JG, Liu TZ, Guo CC, Fan XX, Zhang X, Hu WH, Cai XY: Meta-analysis of the clinical characteristics and prognostic relevance of NOTCH1 and FBXW7 mutation in T-cell acute lymphoblastic leukemia. Oncotarget 2017, 8(39):66360-66370.(共同通讯作者) 77. He SS, Chen Y, Wang HZ, Shen XM, Sun P, Dong J, Liao XB, Guo GF, Chen JG, Xia LP, Hu PL, Qiu HJ, Liu SS, Zhou YX, Wang W, Hu WH, Cai XY: Loss of LKB1 Expression Decreases the Survival and Promotes Laryngeal Cancer Metastasis. J Cancer 2017, 8(17):3548-3554.(共同通讯作者) 78. He SS, Chen Y, Shen XM, Wang HZ, Sun P, Dong J, Guo GF, Chen JG, Xia LP, Hu PL, Qiu HJ, Liu SS, Zhou YX, Wang W, Hu WH, Cai XY: DNA-dependent protein kinase catalytic subunit functions in metastasis and influences survival in advanced-stage laryngeal squamous cell carcinoma. J Cancer 2017, 8(12):2410-2416.(共同通讯作者) 79. Xu C, Sun R, Tang LL, Chen L, Li WF, Mao YP, Zhou GQ, Guo R, Lin AH, Ma J, Hu WH: Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis. Oral oncology 2018, 78:37-45. (共同通讯作者) 80. Xu Y, Rong X, Hu W, Huang X, Li Y, Zheng D, Cai Z, Zuo Z, Tang Y: Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial. International journal of radiation oncology, biology, physics 2018, 101(5):1087-1095.(共同第一作者)

推荐链接
down
wechat
bug